Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 6Th February, 2024

 This is to inform that the Board of Directors of the Company has, at its meeting held on Tuesday, 6th February, 2024 (i.e. today), inter-alia, considered and approved the following items: 1. The Un-audited Financial Results of the Company for the quarter & nine months ended 31st December, 2023. 2. Appointed Mr. Sandip Somany (DIN 00053597) as an Independent Director with effect from 1st April, 2024 This is for your information and record.
06-02-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has received intimation from the shareholders on 27th january,2024, regarding loss of share certificates. As per details given below: 1. Robert Mao Folio No- 14705, No. of Shares- 200, Certificate Nos- 106098- 106099, Distinctive Nos- 78763301-78763500. 2. Ritu Chawla JT. Janak Raj Chawla Folio No- 21675, No. of shares-100, Certificate No-128289, Distinctive No- 0982401-80982500
29-01-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Board Meting To Consider And Approve Unaudited Financial Results For Quarter And 9 Months Ended 31.12.2023

 INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 6th February, 2024, to consider and approve, the unaudited financial results for the quarter and nine months ended 31st December, 2023.
27-01-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Enclosed please find herewith a certificate dated 5th january,2024, issued by M/S Link Intime India Pvt. Ltd., registrar & share transfer agent of the company, for the quarter ended 31st December, 2023.
09-01-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

 Closure of Trading window for dealing in shares of the Company w.e.f. 1st January, 2024 till 48 hours after declaration of un-audited financial results for the quarter and nine months ending 31st December, 2023
26-12-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Clarification/ Confirmation On News Item Appearing In "Media/Publication"

 this is with reference to certain allegations made in the UK''s Telegraph Newspaper and subsequent coverage in "Times of India" on 5th December,2023 on alleged Mal Practices with regards to the Kidney Transplant Program @ Indraprastha Medical Corporation Limited. In this connection, it is reiterated that IMCL considers compliance with all Laws Including the TOHO act, as sacrosanct, our detailed clarification on the aforesaid news item is as per annexure A.
05-12-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate

 This is to inform you that the Company has received a letter from Govt. of NCT Delhi (Promoter of the company) intimating about withdrawal of Nomination Of Mr. Jasmine Shah ( Din 08621290) from the board of directors of the company and accordingly Mr. Jasmine Shah has ceased to be the Non Executive Director and Chairman of the Company.
02-12-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform that the Company has issued duplicate share Certificate in respect of Share Certificates reported to be lost by the shareholder. Details of said Share Certificate are enclosed.
07-11-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 the company has received intimation from shareholder, regarding loss of share certificate as given below: Name: K S Mehta Folio No: 27406 No. of Shares: 1000 Certificate Nos: 5561,135230,173799-173800,175499-175504 Distinctive No: 73719601-73719700,82309601-82309700,72087501-72087700,72257501-72258100
04-11-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 we hereby submit copies of the public notice of the financial results, published on 4th November,2023, in the "Financial Express", all India editions, in English language and in "Jansatta", Delhi edition, in Hindi Language.
04-11-2023
Next Page
Close

Let's Open Free Demat Account